Skip to main content

PDUFA: Information About Reauthorization

HEHS-97-190R Published: Jul 21, 1997. Publicly Released: Aug 05, 1997.
Jump To:

Highlights

Pursuant to a congressional request, GAO responded to questions about the Food and Drug Administration's (FDA) carry-over account and its implications regarding reduction in force (RIF) notices should the Prescription Drug User Fee Act (PDUFA) not be reauthorized.

Full Report

Full Report (8 pages)

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs
media@gao.gov

Public Inquiries

Contact Us

Topics

Auditing and Financial Management
Administrative costsAuthorizing legislationFederal employeesGovernment collectionsPharmaceutical industryReductions in forceUnexpended budget balancesUser feesPrescription drugsPersonnel management